was read the article
array:23 [ "pii" => "S0001731017300078" "issn" => "00017310" "doi" => "10.1016/S0001-7310(17)30007-8" "estado" => "S300" "fechaPublicacion" => "2016-09-01" "aid" => "70042" "copyright" => "Elsevier España, S.L.U. y AEDV" "copyrightAnyo" => "2016" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2016;107 Supl 2:32-42" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 374 "formatos" => array:3 [ "EPUB" => 5 "HTML" => 143 "PDF" => 226 ] ] "itemSiguiente" => array:18 [ "pii" => "S000173101730008X" "issn" => "00017310" "doi" => "10.1016/S0001-7310(17)30008-X" "estado" => "S300" "fechaPublicacion" => "2016-09-01" "aid" => "70043" "copyright" => "Elsevier España, S.L.U. y AEDV" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2016;107 Supl 2:43-50" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 99 "formatos" => array:3 [ "EPUB" => 4 "HTML" => 45 "PDF" => 50 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Experiencia clínica del uso de adalimumab en el manejo de la hidradenitis supurativa. Comparando las tasas de respuesta con la enfermedad de Crohn" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "43" "paginaFinal" => "50" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Clinical experience of the use of adalimumab in the management of hidradenitis suppurativa. Comparison of response rates with Crohn disease" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "B. Moyano, A. Clemente, I. Marín-Jiménez, A. Martorell" "autores" => array:4 [ 0 => array:2 [ "nombre" => "B." "apellidos" => "Moyano" ] 1 => array:2 [ "nombre" => "A." "apellidos" => "Clemente" ] 2 => array:2 [ "nombre" => "I." "apellidos" => "Marín-Jiménez" ] 3 => array:2 [ "nombre" => "A." "apellidos" => "Martorell" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S000173101730008X?idApp=UINPBA000044" "url" => "/00017310/00000107000000S2/v1_201701100052/S000173101730008X/v1_201701100052/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0001731017300066" "issn" => "00017310" "doi" => "10.1016/S0001-7310(17)30006-6" "estado" => "S300" "fechaPublicacion" => "2016-09-01" "aid" => "70041" "copyright" => "Elsevier España, S.L.U. y AEDV" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Actas Dermosifiliogr. 2016;107 Supl 2:27-31" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 96 "formatos" => array:3 [ "EPUB" => 4 "HTML" => 39 "PDF" => 53 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Hidradenitis supurativa y enfermedad de Crohn perianal: diagnóstico diferencial" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "27" "paginaFinal" => "31" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Hidradenitis suppurativa and perianal Crohn disease: differential diagnosis" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. Bassas-Vila, Y. González Lama" "autores" => array:2 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Bassas-Vila" ] 1 => array:2 [ "nombre" => "Y." "apellidos" => "González Lama" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017300066?idApp=UINPBA000044" "url" => "/00017310/00000107000000S2/v1_201701100052/S0001731017300066/v1_201701100052/es/main.assets" ] "es" => array:11 [ "idiomaDefecto" => true "titulo" => "Manejo del paciente con hidradenitis supurativa" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "32" "paginaFinal" => "42" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "A. Martorell, A. Caballero, Y. González Lama, D. Jiménez-Gallo, M. Lázaro Serrano, J. Miranda, J.C. Pascual, L. Salgado-Boquete, I. Marín-Jiménez" "autores" => array:9 [ 0 => array:4 [ "nombre" => "A." "apellidos" => "Martorell" "email" => array:1 [ 0 => "antmarto@hotmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "A." "apellidos" => "Caballero" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Y." "apellidos" => "González Lama" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "D." "apellidos" => "Jiménez-Gallo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 4 => array:3 [ "nombre" => "M." "apellidos" => "Lázaro Serrano" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] ] ] 5 => array:3 [ "nombre" => "J." "apellidos" => "Miranda" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 6 => array:3 [ "nombre" => "J.C." "apellidos" => "Pascual" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "aff0030" ] ] ] 7 => array:3 [ "nombre" => "L." "apellidos" => "Salgado-Boquete" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">g</span>" "identificador" => "aff0035" ] ] ] 8 => array:3 [ "nombre" => "I." "apellidos" => "Marín-Jiménez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:7 [ 0 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital de Manises, Valencia, España" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Gastroenterología, Hospital General Universitario Gregorio Marañón, Madrid, España" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Unidad de Enfermedad Inflamatoria Intestinal, Servicio de Aparato Digestivo, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, España" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Unidad de Gestión Clínica de Dermatología Médico-Quirúrgica y Venereología, Hospital Universitario Puerta del Mar, Servicio Andaluz de Salud, Cádiz, España" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital Universitario Basurto, Bilbao, España" "etiqueta" => "e" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Servicio de Dermatología, Hospital General de Alicante, Alicante, España" "etiqueta" => "f" "identificador" => "aff0030" ] 6 => array:3 [ "entidad" => "Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, España" "etiqueta" => "g" "identificador" => "aff0035" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "*" "correspondencia" => "Autor para correspondencia." ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Management of patients with hidradenitis suppurativa" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "PalabrasClave" => array:2 [ "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec785658" "palabras" => array:4 [ 0 => "Hidradenitis supurativa" 1 => "Tratamiento" 2 => "Infliximab" 3 => "Adalimumab" ] ] ] "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec785659" "palabras" => array:4 [ 0 => "Hidradenitis suppurativa" 1 => "Treatment" 2 => "Infliximab" 3 => "Adalimumab" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">La hidradenitis supurativa es una enfermedad inflamatoria crónica con una alta prevalencia en la población. Su tratamiento comprende un abordaje médico y quirúrgico. El tratamiento médico se basa en el uso de antibióticos, retinoides y fármacos antiinflamatorios, donde la terapia biológica anti-TNFα (infliximab y adalimumab) ocupa el papel central en el tratamiento de la hidradenitis supurativa moderada-grave con el mayor grado de evidencia científica. Actualmente, adalimumab es el único fármaco indicado en ficha técnica para el tratamiento de esta patología. Debido a los pocos ensayos clínicos terapéuticos en hidradenitis supurativa, todavía no existe una guía terapéutica con evidencia sólida, y la mayoría de fármacos tienen un nivel de evidencia bajo. Sin embargo, el tratamiento precoz en pacientes con hidradenitis supurativa, probablemente pueda disminuir las complicaciones derivadas de esta. En esta revisión se analizan los diferentes tratamientos utilizados en esta enfermedad dermatológica y se aporta un algoritmo terapéutico con diferentes opciones de tratamiento.</p></span>" ] "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Hidradenitis suppurativa (HS) is a chronic inflammatory disease with a high prevalence in the population. Treatment options are both medical and surgical. Medical treatment is based on the use of antibiotics, retinoids, and anti-inflammatory drugs, in which anti-TNFα agents (infliximab y adalimumab) play a central role in the treatment of moderate-to-severe HS and enjoy the highest level of scientific support. Currently, adalimumab is the only drug approved in the summary of product characteristics for the treatment of this disease. Due to the scarcity of clinical trials in HS, there is still no therapeutic guideline backed by solid evidence and the evidence for most drugs is low. However, early treatment in patients with HS would probably reduce the complications of this disease. This review analyses the distinct treatments used in this dermatological disease and provides a therapeutic algorithm with different treatment options.</p></span>" ] ] ] "idiomaDefecto" => "es" "url" => "/00017310/00000107000000S2/v1_201701100052/S0001731017300078/v1_201701100052/es/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/00017310/00000107000000S2/v1_201701100052/S0001731017300078/v1_201701100052/es/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017300078?idApp=UINPBA000044" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 20 | 28 | 48 |
2024 October | 134 | 146 | 280 |
2024 September | 117 | 112 | 229 |
2024 August | 133 | 111 | 244 |
2024 July | 118 | 115 | 233 |
2024 June | 149 | 112 | 261 |
2024 May | 113 | 157 | 270 |
2024 April | 116 | 111 | 227 |
2024 March | 83 | 123 | 206 |
2024 February | 83 | 144 | 227 |
2024 January | 74 | 108 | 182 |
2023 December | 78 | 83 | 161 |
2023 November | 82 | 134 | 216 |
2023 October | 70 | 115 | 185 |
2023 September | 78 | 61 | 139 |
2023 August | 74 | 81 | 155 |
2023 July | 93 | 126 | 219 |
2023 June | 69 | 87 | 156 |
2023 May | 83 | 174 | 257 |
2023 April | 68 | 72 | 140 |
2023 March | 73 | 101 | 174 |
2023 February | 50 | 66 | 116 |
2023 January | 67 | 81 | 148 |
2022 December | 82 | 102 | 184 |
2022 November | 64 | 122 | 186 |
2022 October | 68 | 117 | 185 |
2022 September | 65 | 91 | 156 |
2022 August | 49 | 96 | 145 |
2022 July | 58 | 102 | 160 |
2022 June | 102 | 96 | 198 |
2022 May | 65 | 102 | 167 |
2022 April | 56 | 118 | 174 |
2022 March | 63 | 117 | 180 |
2022 February | 41 | 79 | 120 |
2022 January | 52 | 112 | 164 |
2021 December | 33 | 74 | 107 |
2021 November | 53 | 93 | 146 |
2021 October | 66 | 115 | 181 |
2021 September | 32 | 85 | 117 |
2021 August | 69 | 96 | 165 |
2021 July | 56 | 102 | 158 |
2021 June | 56 | 101 | 157 |
2021 May | 40 | 78 | 118 |
2021 April | 162 | 159 | 321 |
2021 March | 52 | 68 | 120 |
2021 February | 41 | 55 | 96 |
2021 January | 40 | 72 | 112 |
2020 December | 52 | 53 | 105 |
2020 November | 31 | 53 | 84 |
2020 October | 38 | 55 | 93 |
2020 September | 44 | 66 | 110 |
2020 August | 40 | 40 | 80 |
2020 July | 30 | 32 | 62 |
2020 June | 37 | 53 | 90 |
2020 May | 45 | 52 | 97 |
2020 April | 19 | 55 | 74 |
2020 March | 22 | 29 | 51 |
2020 February | 0 | 6 | 6 |
2020 January | 0 | 4 | 4 |
2019 December | 0 | 2 | 2 |
2019 November | 1 | 16 | 17 |
2019 October | 1 | 4 | 5 |
2019 September | 0 | 10 | 10 |
2019 August | 0 | 2 | 2 |
2019 July | 0 | 2 | 2 |
2019 June | 3 | 6 | 9 |
2019 May | 2 | 10 | 12 |
2019 April | 0 | 14 | 14 |
2019 March | 6 | 7 | 13 |
2019 February | 35 | 25 | 60 |
2019 January | 1 | 6 | 7 |
2018 December | 2 | 8 | 10 |
2018 November | 24 | 16 | 40 |
2018 October | 3 | 19 | 22 |
2018 September | 2 | 8 | 10 |
2018 August | 1 | 0 | 1 |
2018 July | 1 | 0 | 1 |
2018 June | 0 | 1 | 1 |
2018 May | 1 | 1 | 2 |
2018 April | 1 | 4 | 5 |
2018 March | 0 | 5 | 5 |
2018 February | 5 | 4 | 9 |
2018 January | 4 | 4 | 8 |
2017 December | 3 | 0 | 3 |
2017 November | 5 | 6 | 11 |
2017 October | 7 | 2 | 9 |
2017 September | 3 | 3 | 6 |
2017 August | 1 | 1 | 2 |
2017 July | 5 | 6 | 11 |
2017 June | 5 | 2 | 7 |
2017 May | 7 | 2 | 9 |
2017 April | 4 | 6 | 10 |
2017 March | 4 | 7 | 11 |
2017 February | 2 | 4 | 6 |
2017 January | 4 | 5 | 9 |